SABBY MANAGEMENT, LLC 13D/13G Filings for Actinium Pharmaceuticals, Inc. (ATNM)

SABBY MANAGEMENT, LLC 13D and 13G filings for Actinium Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-01-05
4:40 pm
Purchase
2020-12-3113GActinium Pharmaceuticals, Inc.
ATNM
SABBY MANAGEMENT, LLC630,637
11.000%
630,637increase
(New Position)
Filing